PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Naproxen plus acid-blocking drug shows promise in preventing bladder cancer

Combining naproxen and omeprazole, which reduces GI side effects in humans, prevented bladder cancer in animal model

2015-03-11
(Press-News.org) ANN ARBOR, Mich. -- The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds.

A new study suggests there may be ways to reduce these dangerous side effects.

Collaborators from the University of Michigan, the National Cancer Institute and the University of Alabama looked at naproxen, which is known to have a lower cardiovascular risk than other NSAIDs. Naproxen, like most NSAIDs and aspirin, does increase the risk for gastric ulcers or bleeding. Here, the researchers used the proton pump inhibitor omeprazole, a commonly used acid inhibitor, in combination with naproxen and tested its effects on cancer prevention in a rat model of bladder cancer.

They found that naproxen reduced the incidence of bladder cancer by 75 percent in rats. Omeprazole by itself did not affect the development of cancer but it also did not interfere with the effect of naproxen at preventing tumors. The rats who received naproxen alone or naproxen with omeprazole developed cancer at similarly low rates, while all rats receiving omeprazole alone or no treatment developed bladder cancer.

Clinical data in humans has previously shown combining omeprazole plus naproxen reduced gastric toxicity roughly 70 percent.

The authors also found that intermittent dosing with naproxen (three weeks on the drugs, followed by three weeks off) was highly effective and likely to reduce gastric toxicity. However, it does not have the clear clinical data supporting reduced gastric toxicity associated with naproxen and omeprazole.

"Our study shows that naproxen works just as well with a proton pump inhibitor as without. This provides proof of principle that this could be a valuable cancer prevention strategy and one hopes it can advance quickly to a clinical trial for those at high risk of colon, esophageal, squamous cell skin cancer or potentially other cancers," says lead study author Ronald A. Lubet, Ph.D., a scientist with the Chemopreventive Agent Development Research Group at the National Cancer Institute.

"The ability to reduce the gastric effects of NSAIDs adds another element to ongoing discussions of whether the NSAID aspirin might be applicable to prevention studies in a more general population, since the gastric toxicity of even low-dose aspirin has been considered a hurdle," he adds.

The current study is published in the American Association for Cancer Research journal Cancer Prevention Research.

"Naproxen is a great candidate for chemoprevention. It comes with a risk of gastrointestinal side effects, but if you can mitigate that with a co-prescription, it's possibly an ideal chemoprevention drug," says study author James Scheiman, M.D., professor of gastroenterology at the University of Michigan Medical School. Scheiman has studied the use of NSAIDs in chemoprevention and has co-authored guidelines on the gastrointestinal risks of aspirin and NSAIDs.

The combination of naproxen plus a proton pump inhibitor is already used in people with arthritis. Naproxen and omeprazole are both available over the counter.

The authors hope to plan a clinical trial to look at naproxen plus omeprazole in people at high risk of colon or other cancers. This is not currently available. Patients seeking more information about cancer prevention can call the U-M Cancer AnswerLine at 800-865-1125.

INFORMATION:

Additional authors: Ann Bode, Hormel Institute at the University of Minnesota; Jonathan White, Midwest Research Institute in Kansas City, Mo.; Lori Minasian, Daniel L. Boring and Vernon E. Steele, NCI; M. Margaret Juliana and Clinton J. Grubbs, University of Alabama at Birmingham

Funding: National Cancer Institute grant N01-CN43301

Disclosure: Scheiman has served as a paid expert to pharmaceutical companies that market NSAIDs and proton pump inhibitors.

Reference: Cancer Prevention Research, "Naproxen Prevention of Urinary Bladder Cancer," published online March 11, 2015

Resources: U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, http://www.mcancer.org
Clinical trials at U-M, http://www.mcancer.org/clinicaltrials
mCancerTalk blog, http://uofmhealthblogs.org/cancer



ELSE PRESS RELEASES FROM THIS DATE:

Deadly to cancer cells only

2015-03-11
Parvoviruses are a class of viruses that normally infect rodents; in humans, they do not cause any disease symptoms. However, they are able to infect and kill cancer cells. The details behind this biological selectivity on the part of the viruses have not been understood until now. "Since the viruses might soon play a role in cancer medicine, it is important to know why they replicate exclusively in tumor cells in humans," says virologist Dr. Jürg Nüesch from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). In order to complete their ...

New genetic evidence resolves origins of modern Japanese

2015-03-11
Was there a single migration event or gradual mixing of cultures that gave rise to modern Japanese? According to current theory, about 2,000-3,000 years ago, two populations, the hunter-gatherer Jomon from the Japanese archipelago, and the agricultural Yayoi from continental East Asia, intermingled to give rise to the modern Japanese population. However, some researchers have suggested otherwise, with the Jomon culture gradually transformed into the Yayoi culture without large migrations into modern day Japan. To resolve the controversy, researchers Oota, Mano, Nakagome ...

Stem cells in the brain: Limited self-renewal

2015-03-11
The generation of neurons (neurogenesis) in humans is predominantly limited to development; in the adult stage it takes place in only a few regions of the brain. These regions contain neural stem cells that generate neurons in a process with various intermediary stages. Stem cell renewal is limited - total number drops Until now it was thought that maintaining the stem cell pool was based on the self-renewal of individual stem cells. The team of scientists headed by Dr. Jovica Ninkovic and Professor Dr. Magdalena Götz were able to refute this: Both the self-renewal ...

It's sound -- Bristol Pound encourages community unity

2015-03-11
There is a rapidly growing momentum driving the development of mobile payment systems. New research has shown systems, such as the Bristol Pound, can have a positive effect on the local community by encouraging consumers to support and value their local businesses. The paper, which will be presented at this month's ACM Conference on Computer-Supported Cooperative Work and Social Computing (ACM CSCW 2015) [14-18 March], looks at user interactions and practices around mobile payment systems. The research, led by Dr Mark Perry at Brunel University London and visiting ...

Palm tree Coco de mer performs 'parental care' and modifies its habitat

2015-03-11
Tourists are familiar with the Lodoicea maldivica palm, also called coco de mer, mainly because of their bizarrely shaped fruits. Scientists, however, are fascinated by the huge plants - which are abundant on the Seychelles islands of Praslin and Curieuse - for entirely different reasons. The coco de mer palm engages in a lot of effort for reproduction, producing large amounts of pollen and huge fruits that cannot be spread around, but rather fall to the ground at the base. "This is nan enormous commitment of energy in very nutrient-poor soil - it does not really make ...

DNA-directed RNA transcription may have profound adaptability

2015-03-11
The central dogma of molecular biology describes the flow of genetic information. It was first described by Francis Crick in 1956 as one-way traffic: as: "DNA makes RNA and RNA makes protein." A recent paper published in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, however suggests that, rather than being a one-way street, DNA-directed RNA transcription may have profound adaptability. The authors of the paper showed a conceptually novel relationship between the genotype (DNA) and the phenotype (the products of the transcription of DNA). The ...

Brain processes ongoing pain more emotionally

2015-03-11
This news release is available in German. A momentary lapse of concentration is all it takes for a finger to become trapped or sprain an ankle - and it hurts. Pain is the body's protective mechanism and a complex neurological phenomenon. Moreover, ongoing pain in the sense of chronic pain can be a disease. Scientists from Technische Universität München (TUM) have now demonstrated that already during a few minutes of ongoing pain, the underlying brain activity changes by shifting from sensory to emotional processes. In their experiments, Prof. Markus Ploner, ...

How changes in body weight affect the human metabolism

2015-03-11
Until now there have been few molecular epidemiological studies regarding the effects of weight changes on metabolism in the general population. In a recent study conducted and funded within the framework of the Competence Network Obesity, researchers at the Institute of Epidemiology II at Helmholtz Zentrum München (HMGU) evaluated molecular data of the KORA study*. "Techniques such as metabolomics and transcriptomics allow the simultaneous determination of a variety of low molecular weight metabolites or gene activities (transcripts of genes) using high-throughput ...

Religion and support for birth control health coverage can mix

2015-03-11
ANN ARBOR, Mich. -- New research debunks the assumption that a woman's religion predicts her views on policies affecting reproductive health care such as insurance coverage for birth control. Even when it comes to policies that have sometimes been characterized as going against Christian views - such as the Affordable Care Act mandate for employer-provided contraception coverage- religious women's opinions are mixed, finds the nationally-representative study by the University of Michigan . Protestants and Catholics were most likely to agree that employer health plans ...

Promising Alzheimer's treatment moves toward clinical trials

Promising Alzheimers treatment moves toward clinical trials
2015-03-11
EAST LANSING, Mich. - A promising new natural treatment for Alzheimer's disease is moving toward clinical trials. This will be a major step forward as there is nothing on the market that slows the progression of Alzheimer's. Muraleedharan Nair, Michigan State University natural products chemist, has patented a botanical compound, withanamides. His spinoff company, Natural Therapeutics, will begin the trials as soon as funding is in place. To date, none of the major pharmaceutical companies - Merck, Eli Lilly, Bristol-Myers Squibb - have been able to produce an effective ...

LAST 30 PRESS RELEASES:

Is it time to retire the best-before date?

An electrifying discovery may help doctors deliver more effective gene therapies

Lurie Children’s Hospital first-in-pediatrics to use technology that lights up lung cancer during surgery

$3.6 million to advance nuclear energy awarded to U-M

Two UT Arlington faculty honored for outstanding research

UT Arlington student links worm behavior to brain disease

Uncovering the secret of long-lived stem cells

The question for online educational platforms: offer courses following a schedule or release them on demand?

Study: racial bias is no 'false alarm' in policing

Ecological Society of America announces 2024 Fellows

Mass General Brigham researchers identify potential drivers of chronic allergic inflammation

Scientists solve chemical mystery at the interface of biology and technology

Shaping the Future of Neuroendocrine Tumor Management

Scientists show ancient village adapted to drought, rising seas

Cover paper: Senescent characteristics of human corneal endothelial cells upon UV-A exposure

Activity in a room stirs up nanoparticles left over from consumer sprays

NASA’s Webb maps weather on planet 280 light-years away

Webb captures top of iconic horsehead nebula in unprecedented detail

Researchers reveal a new approach for treating degenerative diseases

People who inject drugs are transitioning to smoking

AI speech analysis may aid in assessing and preventing potential suicides, says Concordia PhD candidate Alaa Nfissi

New clinical practice guideline provides evidence-based recommendations for Age-related Hearing Loss (ARHL)

Low-intensity grazing is locally better for biodiversity but challenging for land users, a new study shows

An omega-6 fatty acid may reduce the risk for bipolar disorder

New breast cancer screening recommendations aim to address health inequities, especially among Black women

AGS honors expert and emerging geriatrics leaders at 2024 virtual annual scientific meeting (#AGS24)

Protecting endangered monkeys from poachers, habitat loss

China’s bid to decarbonize may have hidden costs

Climate change and mercury pollution stressed plants for millions of years

Stowers Institute for Medical Research appoints new Assistant Investigator

[Press-News.org] Naproxen plus acid-blocking drug shows promise in preventing bladder cancer
Combining naproxen and omeprazole, which reduces GI side effects in humans, prevented bladder cancer in animal model